TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17012108

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (45 mg daily)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (45 mg daily) plus Vitamin D3 (0.75 microg 1alpha‐hydroxyvitamin D3 daily)
Number of subjects: 34
Study: 15271700

Group type: COMPARATOR
Intervention: IV bolus of phenylephrine (50‐100 microg) or nitroglycerine (300‐500 microg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Rapid infusion of 500 mL of a gelatin solution
Number of subjects: 42
Study: 10669675

Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by radiation therapy (60 Gy at 2.0 Gy per fraction)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation (1.2 Gy per fraction delivered twice daily to a total dose of 69.6 Gy)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Standard radiation (2.0 Gy per fraction to 60 Gy)
Number of subjects: 458
Study: 9193736

Group type: EXPERIMENTAL
Intervention: m‐CPP (0.25 mg/kg body weight)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: m‐CPP
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8437010

Group type: EXPERIMENTAL
Intervention: 150 mg dextromethorphan daily for 12 weeks
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 300 mg dextromethorphan daily for up to 6 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30686699

Group type: EXPERIMENTAL
Intervention: Azithromycin (1,000 mg before LTx and 250 mg every other day from Day 1 to Day 31 after LTx)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 28606190

Group type: EXPERIMENTAL
Intervention: Public reporting of prescription indicators monthly for one year
Number of subjects: 31460
Study: 26573140

Group type: EXPERIMENTAL
Intervention: Impulsive Lifestyle Counselling (ILC)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 176
Study: 23142856

Group type: EXPERIMENTAL
Intervention: Mobile VCT in rural Vulindlela
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Mobile VCT in urban Soweto
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Mobile VCT in both sites
Number of subjects: 1015
Study: 21172721

Group type: EXPERIMENTAL
Intervention: AZD0837 150 mg
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: AZD0837 300 mg
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard therapy (no treatment, aspirin 75‐325 mg or clopidogrel 75 mg once daily)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: AZD0837 150 mg and 300 mg
Number of subjects: 131
Study: 18662422

Group type: EXPERIMENTAL
Intervention: Supportive care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16829673

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study: 14742786

Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin (80-90 mg/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose amoxicillin (40-45 mg/kg/d)
Number of subjects: 0
Study: 11275035

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (50 microg tablet every 4 hours for a maximum of six doses)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Transcervical Foley catheter (30‐mL Foley catheter placed transcervically with maintenance of traction)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 111
Study: 9313739

Group type: EXPERIMENTAL
Intervention: Power colour flow
Number of subjects: 16

Group type: COMPARATOR
Intervention: Frequency based colour Doppler
Number of subjects: 16
Study: 8439640

Group type: EXPERIMENTAL
Intervention: Trospium chloride
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2420386

Group type: EXPERIMENTAL
Intervention: Dioctyl sodium sulfosuccinate (DS) administered 30 minutes before tetracycline and on -3, -2, and -1 day in the evening before tetracycline administration
Number of subjects: 3

Group type: COMPARATOR
Intervention: Tetracycline products (fast dissolving capsule, slow dissolving capsule, and suspension) without DS
Number of subjects: 3
Study: 30158356

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edoxaban tosilate hydrate
Number of subjects: 0
Study: 27405724

Group type: EXPERIMENTAL
Intervention: Promotion group (weekly emailed tips emphasizing social network interactions for walking)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Activity group (weekly tips + evidence‐based online fitness walking intervention)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Social Networks group (weekly tips + online networking site for walking)
Number of subjects: 308

Group type: COMPARATOR
Intervention: All intervention groups
Number of subjects: 308
Study: 24786143

Group type: EXPERIMENTAL
Intervention: High-potency statin regimen (simvastatin 40 mg/day for 1 month, then simvastatin 80 mg/day)
Number of subjects: 8659

Group type: COMPARATOR
Intervention: Delayed moderate-potency statin strategy (placebo for 4 months, then simvastatin 20 mg/day)
Number of subjects: 8659

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 8659

Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day
Number of subjects: 8659

Group type: EXPERIMENTAL
Intervention: High-potency statin regimen
Number of subjects: 8659

Group type: COMPARATOR
Intervention: Moderate-potency statin regimen
Number of subjects: 8659
Study: 22672915

Group type: EXPERIMENTAL
Intervention: Virtual Reality Group (VRG) - received three different Nintendo® Wii FIT balance interventions three times per week for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG) - received no intervention
Number of subjects: 40
Study: 19652922

Group type: EXPERIMENTAL
Intervention: Iron-supplemented group (ISG) received 150 mg ferrous sulfate once weekly for 16 weeks.
Number of subjects: 193

Group type: COMPARATOR
Intervention: Iron-unsupplemented group (IUG) received nothing.
Number of subjects: 193
Study: 18813039

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg propofol plus 1.5 microg/kg remifentanil
Number of subjects: 98

Group type: COMPARATOR
Intervention: 4.0 mg/kg propofol plus 0.5 microg/kg remifentanil
Number of subjects: 98
Study: 16333242

Group type: EXPERIMENTAL
Intervention: Adjuvant endocrine therapy
Number of subjects: 85
Study: 12947367

Group type: EXPERIMENTAL
Intervention: PEG-Sak at 0.01 mg/kg
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: PEG-Sak at doses of 0.01875 to 0.0375 mg/kg (n = 314)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: PEG-Sak at 0.05 mg/kg (n = 23)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Recombinant tissue plasminogen activator (rt-PA)
Number of subjects: 378
Study: 10371778

Group type: EXPERIMENTAL
Intervention: Creutzfeldt‐Jakob disease cases
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (age and sex matched)
Number of subjects: 26
Study: 8902990

Group type: EXPERIMENTAL
Intervention: Colorectal cancer patients preoperatively
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Colorectal cancer patients with advanced disease
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Colorectal cancer patients postoperatively with DVT
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All patients postoperatively
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-malignancy control group
Number of subjects: 123
Study: 1853789

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with vitamins A, C and E
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6352036

Group type: EXPERIMENTAL
Intervention: Propranolol-hydralazine combination (40 mg/25 mg, 80 mg/25 mg, 80 mg/50 mg, 120 mg/50 mg, 160 mg/50 mg, 160 mg/100 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Propranolol-hydralazine combination
Number of subjects: 83
Study: 30648491

Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted THA
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional manual THA
Number of subjects: 75
Study: 30354641

Group type: EXPERIMENTAL
Intervention: High-Speed Rotational Atherectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified Balloons
Number of subjects: 0
Study: 26856695

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 24864484

Group type: EXPERIMENTAL
Intervention: Dynamic electroneurostimulation (DENS)
Number of subjects: 2012
Study: 22152430

Group type: EXPERIMENTAL
Intervention: Porridge with milk (Milk group)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Porridge with beef (Meat group)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Plain millet porridge (Plain group)
Number of subjects: 274
Study: 21290831

Group type: EXPERIMENTAL
Intervention: Acupuncture at Shuigou (GV 26), Neiguan (PC 6), and Sanyinjiao (SP 6)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Functional electric stimulation to stimulate the affected muscles of the upper limbs
Number of subjects: 102
Study: 17998085

Group type: EXPERIMENTAL
Intervention: Symbols for SOR presentation
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Symbols for QOE presentation
Number of subjects: 84
Study: 16521849

Group type: EXPERIMENTAL
Intervention: Ribose (3 g ribose + 150 microg folate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (150 mL)
Number of subjects: 12
Study: 12521402

Group type: EXPERIMENTAL
Intervention: Active inhalers
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo inhalers (control)
Number of subjects: 400
Study: 10520911

Group type: EXPERIMENTAL
Intervention: Epidural infusion
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Paravertebral infusion
Number of subjects: 50
Study: 7486823

Group type: EXPERIMENTAL
Intervention: Boehmite (Rocgel)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Ranitidine (anti-H2)
Number of subjects: 64
Study: 1778538

Group type: EXPERIMENTAL
Intervention: Sustained-release acebutolol (500 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional acebutolol (200 mg tid)
Number of subjects: 10
Study: 7035153

Group type: EXPERIMENTAL
Intervention: Prophylactic sclerotherapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 71
Study: 30707227

Group type: EXPERIMENTAL
Intervention: Thyrotropin suppression through levothyroxine therapy
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Lateral neck lymph node metastases
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Distant metastases
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Poorly differentiated histology
Number of subjects: 867
Study: 28424187

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) for 6 months
Number of subjects: 166

Group type: COMPARATOR
Intervention: Habitual diet (HabDiet) for 6 months (control)
Number of subjects: 166
Study: 26407547

Group type: EXPERIMENTAL
Intervention: Opt-out recruitment strategies (on-site recruitment)
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Opt-out recruitment strategies (routine care letters)
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Opt-in recruitment strategies
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Relying on providers at the hospital (opt-in strategy)
Number of subjects: 1562
Study: 23317340

Group type: EXPERIMENTAL
Intervention: Bee venom acupuncture
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham bee venom acupuncture
Number of subjects: 54
Study: 21931661

Group type: EXPERIMENTAL
Intervention: Aprepitant 125 mg QD (Low)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aprepitant 250 mg QD (High)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study: 19150179

Group type: EXPERIMENTAL
Intervention: PCOS patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: BMI-matched healthy controls
Number of subjects: 32
Study: 17329466

Group type: EXPERIMENTAL
Intervention: Quetiapine (200-800 mg/day)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Olanzapine (7.5-30.0 mg/day)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Risperidone (1.5-6.0 mg/day)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 114
Study: 15389983

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10930903

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg daily plus amoxycillin 1 g b.d. and clarithromycin 250 mg b.d. for 1 week (Group PAC)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg daily for 1 month (Group P)
Number of subjects: 69
Study: 9207754

Group type: EXPERIMENTAL
Intervention: Low-dose Convit vaccine plus MDT
Number of subjects: 125

Group type: COMPARATOR
Intervention: BCG vaccination plus MDT
Number of subjects: 125

Group type: COMPARATOR
Intervention: Killed Mycobacterium leprae vaccine plus MDT
Number of subjects: 125

Group type: COMPARATOR
Intervention: MDT alone
Number of subjects: 125
Study: 1539776

Group type: EXPERIMENTAL
Intervention: omeprazole 40 mg 12 hourly alone
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: omeprazole 40 mg 12 hourly with sodium citrate
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg 6 hourly with sodium citrate
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: sodium citrate
Number of subjects: 162
Study: 3932052

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 micrograms
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 421

Group type: COMPARATOR
Intervention: Cimetidine 300 mg
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Non-smokers in misoprostol groups
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Smokers in misoprostol groups
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 421
Study: 31718597

Group type: EXPERIMENTAL
Intervention: 5-month multi-component intervention including school lunchbox nutrition guidelines, curriculum lessons, information pushed to parents via a school-based communication application, and additional parent resources.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control arm (standard school practices)
Number of subjects: 36
Study: 29339351

Group type: EXPERIMENTAL
Intervention: Higher target blood pressure (70-80 mmHg) during cardiopulmonary bypass
Number of subjects: 197

Group type: COMPARATOR
Intervention: Lower target blood pressure (40-50 mmHg) during cardiopulmonary bypass
Number of subjects: 197
Study: 26894485

Group type: EXPERIMENTAL
Intervention: loratadine 10 mg daily for 7 days
Number of subjects: 213

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 213
Study: 24315135

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 30
Study: 21887538

Group type: EXPERIMENTAL
Intervention: Press-fit fixation with a porous bone cylinder (P)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Interference screw fixation (I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (P and I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Press-fit fixation (P)
Number of subjects: 20
Study: 19933688

Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 1100
Study: 18091289

Group type: EXPERIMENTAL
Intervention: Telephone-only motivational interviewing (MI) intervention with a pedometer and monthly MI telephone calls over 6 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group with equal number of telephone calls without MI content
Number of subjects: 86
Study: 15939582

Group type: EXPERIMENTAL
Intervention: Zileuton (600 mg) four times a day for 5 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 12835432

Group type: EXPERIMENTAL
Intervention: Pre-coated brackets
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-pre-coated brackets
Number of subjects: 33
Study: 11074181

Group type: EXPERIMENTAL
Intervention: Levetiracetam 1000 mg per day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Levetiracetam 2000 mg per day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Levetiracetam 3000 mg per day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Levetiracetam 4000 mg per day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Levetiracetam (any dose)
Number of subjects: 29
Study: 9004249

Group type: EXPERIMENTAL
Intervention: NG‐nitro‐L‐arginine methyl ester (L‐NAME) 40 micrograms/kg injected plus 50 micrograms/kg infused over 60 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NG‐nitro‐L‐arginine methyl ester (L‐NAME)
Number of subjects: 0
Study: 1627424

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cyclophosphamide, methotrexate, fluorouracil, and prednisone for six cycles)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 788
Study: 7458118

Group type: EXPERIMENTAL
Intervention: Cephalozoline administered 1 hour before and 5 and 12 hours after surgery
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Thiamphenicol administered 1 hour before and 5 and 12 hours after surgery
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Combination of cephalozoline and thiamphenicol administered 1 hour before and 5 and 12 hours after surgery
Number of subjects: 665

Group type: COMPARATOR
Intervention: No antibiotics administered (control group)
Number of subjects: 665
Study: 31789656

Group type: EXPERIMENTAL
Intervention: Micro-scale computational fluid dynamics (CFD) model applied to small oxygenator prototypes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory oxygenator prototypes tested in vitro with porcine blood
Number of subjects: 0
Study: 28674147

Group type: EXPERIMENTAL
Intervention: Gold Coast Integrated Care (GCIC)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 1500
Study: 25972155

Group type: EXPERIMENTAL
Intervention: Intranasal butorphanol
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Intravenous butorphanol
Number of subjects: 260

Group type: COMPARATOR
Intervention: Intranasal fentanyl
Number of subjects: 260

Group type: COMPARATOR
Intervention: Intravenous saline (control)
Number of subjects: 260
Study: 24021297

Group type: EXPERIMENTAL
Intervention: Formula-based dosing of Genotropin® GH (0.18 to 0.7 mg/kg/week)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard dosing of Genotropin® (0.37 mg/kg/week)
Number of subjects: 316
Study: 20844485

Group type: EXPERIMENTAL
Intervention: Omeprazole (80 mg) with clopidogrel (300 mg loading dose/75 mg/day maintenance dose)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose/75 mg/day maintenance dose) administered 12 hours apart from omeprazole (80 mg)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Clopidogrel (600 mg loading dose/150 mg/day maintenance dose) with omeprazole (80 mg)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Pantoprazole (80 mg) with clopidogrel (300 mg loading dose/75 mg/day maintenance dose)
Number of subjects: 282
Study: 19282345

Group type: EXPERIMENTAL
Intervention: Participants (n = 889)
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Nonparticipants (n = 97)
Number of subjects: 2500
Study: 17845652

Group type: EXPERIMENTAL
Intervention: Lateral interscalene technique (Winnie)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Posterior interscalene technique (Pippa)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Axillary technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vertical infraclavicular technique
Number of subjects: 40
Study: 16918592

Group type: EXPERIMENTAL
Intervention: Insulin detemir (IDet) 0.3 U/kg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Insulin detemir (IDet) 0.6 U/kg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Insulin detemir (IDet) 1.2 U/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: NPH insulin 0.3 IU/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: NPH insulin 0.6 IU/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: NPH insulin 1.2 IU/kg
Number of subjects: 48
Study: 14560411

Group type: EXPERIMENTAL
Intervention: Highly cross-linked, ultrahigh-molecular-weight polyethylenes (UHMWPEs) used in arthroplasty.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro examination of UHMWPEs.
Number of subjects: 0
Study: 10725985

Group type: EXPERIMENTAL
Intervention: Gynera
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Microgynon 30
Number of subjects: 67
Study: 7481865

Group type: EXPERIMENTAL
Intervention: Comprehensive surgical staging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various adjuvant treatments
Number of subjects: 0
Study: 1688988

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (CLS 2210)
Number of subjects: 41
Study: 6992186

Group type: EXPERIMENTAL
Intervention: Reading a confusion color chart based on the principle of interference in color perception
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cold pressure test
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Isometric stress with a hand ergometer
Number of subjects: 5

Group type: COMPARATOR
Intervention: Adaptation phase
Number of subjects: 5
Study: 28543407

Group type: EXPERIMENTAL
Intervention: Mood stabilizer treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 27507930

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined (all participants)
Number of subjects: 17
Study: 25429898

Group type: EXPERIMENTAL
Intervention: OSNAP‐OPAT
Number of subjects: 528